ATE226824T1 - Zusammensetzungen mit u.a. riboflavin zur lokaler schützung von genitalen und rectalen schleimhäuten - Google Patents

Zusammensetzungen mit u.a. riboflavin zur lokaler schützung von genitalen und rectalen schleimhäuten

Info

Publication number
ATE226824T1
ATE226824T1 AT95916739T AT95916739T ATE226824T1 AT E226824 T1 ATE226824 T1 AT E226824T1 AT 95916739 T AT95916739 T AT 95916739T AT 95916739 T AT95916739 T AT 95916739T AT E226824 T1 ATE226824 T1 AT E226824T1
Authority
AT
Austria
Prior art keywords
pct
compositions
genital
salts
derivatives
Prior art date
Application number
AT95916739T
Other languages
English (en)
Inventor
Jean Berque
Original Assignee
Jean Berque
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jean Berque filed Critical Jean Berque
Application granted granted Critical
Publication of ATE226824T1 publication Critical patent/ATE226824T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/525—Isoalloxazines, e.g. riboflavins, vitamin B2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
AT95916739T 1994-04-11 1995-04-11 Zusammensetzungen mit u.a. riboflavin zur lokaler schützung von genitalen und rectalen schleimhäuten ATE226824T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9404232A FR2718353B3 (fr) 1994-04-11 1994-04-11 Compositions pharmaceutiques à base de produits biologiques atoxiques destinées à la protection locale des muqueuses génitales et rectales.
PCT/FR1995/000463 WO1995027491A1 (fr) 1994-04-11 1995-04-11 Compositions d'entre autres la riboflavine pour la protection locale des muqueuses genitales et rectales

Publications (1)

Publication Number Publication Date
ATE226824T1 true ATE226824T1 (de) 2002-11-15

Family

ID=9461934

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95916739T ATE226824T1 (de) 1994-04-11 1995-04-11 Zusammensetzungen mit u.a. riboflavin zur lokaler schützung von genitalen und rectalen schleimhäuten

Country Status (7)

Country Link
US (1) US6020333A (de)
EP (1) EP0732927B1 (de)
AT (1) ATE226824T1 (de)
AU (1) AU2311995A (de)
DE (1) DE69528695T2 (de)
FR (1) FR2718353B3 (de)
WO (1) WO1995027491A1 (de)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1284139B1 (it) * 1996-09-06 1998-05-08 Acraf Composizione farmaceutica comprendente un coenzima utile nel trattamento della sindrome da immunodeficenza acquisita
IN186803B (de) * 1997-02-05 2001-11-10 Panacea Biotec Ltd
CA2302687A1 (en) * 1997-09-11 1999-03-18 Oxigene, Inc. Uses of nicotinamide adenine dinucleotide and its analogs for treatment of malignant and infectious diseases
US7049110B2 (en) * 1998-07-21 2006-05-23 Gambro, Inc. Inactivation of West Nile virus and malaria using photosensitizers
US6277337B1 (en) 1998-07-21 2001-08-21 Gambro, Inc. Method and apparatus for inactivation of biological contaminants using photosensitizers
US20070099170A1 (en) * 1998-07-21 2007-05-03 Navigant Biotechnologies, Inc. Method for treatment and storage of blood and blood products using endogenous alloxazines and acetate
US7498156B2 (en) * 1998-07-21 2009-03-03 Caridianbct Biotechnologies, Llc Use of visible light at wavelengths of 500 to 550 nm to reduce the number of pathogens in blood and blood components
US20030215784A1 (en) * 1998-07-21 2003-11-20 Dumont Larry Joe Method and apparatus for inactivation of biological contaminants using photosensitizers
US6258577B1 (en) 1998-07-21 2001-07-10 Gambro, Inc. Method and apparatus for inactivation of biological contaminants using endogenous alloxazine or isoalloxazine photosensitizers
US6268120B1 (en) 1999-10-19 2001-07-31 Gambro, Inc. Isoalloxazine derivatives to neutralize biological contaminants
US7985588B2 (en) 2000-06-02 2011-07-26 Caridianbct Biotechnologies, Llc Induction of and maintenance of nucleic acid damage in pathogens using riboflavin and light
TW590780B (en) 2000-06-02 2004-06-11 Gambro Inc Additive solutions containing riboflavin
US7648699B2 (en) 2000-06-02 2010-01-19 Caridianbct Biotechnologies, Llc Preventing transfusion related complications in a recipient of a blood transfusion
US6843961B2 (en) * 2000-06-15 2005-01-18 Gambro, Inc. Reduction of contaminants in blood and blood products using photosensitizers and peak wavelengths of light
US9044523B2 (en) 2000-06-15 2015-06-02 Terumo Bct, Inc. Reduction of contaminants in blood and blood products using photosensitizers and peak wavelengths of light
US7012086B1 (en) 2000-06-30 2006-03-14 The Foundation For Innovative Therapies, Inc. Treatment of retrovirus induced derangements with niacin compounds
US6548241B1 (en) 2000-11-28 2003-04-15 Gambro, Inc. Storage solution containing photosensitizer for inactivation of biological contaminants
US6475526B1 (en) 2001-06-05 2002-11-05 Jeffrey B. Smith Zinc containing compositions for anti-viral use
US6855341B2 (en) * 2002-11-04 2005-02-15 Jeffrey B. Smith Anti-viral compositions and methods of making and using the anti-viral compositions
US20080274209A1 (en) * 2002-11-04 2008-11-06 Integritas Pharma, Inc. Methods of treating inflammation
GB2396809A (en) * 2003-01-03 2004-07-07 Vitabiotics Ltd Composition for the treatment of HIV and AIDS
US7153569B2 (en) * 2004-03-19 2006-12-26 Kimberly-Clark Worldwide, Inc. Biodegradable aliphatic-aromatic copolyester films
US7250445B1 (en) * 2005-01-14 2007-07-31 Ehrenpreis Eli D Anti-oxidant suppository for treating radiation proctopathy and other anorectal disorders
EP2205285A2 (de) * 2007-08-01 2010-07-14 CaridianBCT Biotechnologies, LLC Inaktivierung von krankheitserregern in vollblut
US20090054497A1 (en) * 2007-08-21 2009-02-26 Nawaz Ahmad Methods for attaining enhanced sexual wellness using anhydrous compositions
US20090054498A1 (en) * 2007-08-21 2009-02-26 Nawaz Ahmad Anhydrous Compositions Useful for Attaining Enhanced Sexual Wellness
WO2009026073A1 (en) * 2007-08-22 2009-02-26 Caridianbct Biotechnologies, Llc Prevention of transfusion related acute lung injury using riboflavin and light
US9254275B2 (en) * 2007-09-17 2016-02-09 Cornell University Branched chain fatty acids for prevention or treatment of gastrointestinal disorders

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6360910A (ja) * 1986-09-01 1988-03-17 Shiseido Co Ltd 皮膚外用剤
LU87145A1 (fr) * 1988-02-26 1989-09-20 Oreal Methode pour ameliorer l'aspect esthetique de la peau a l'aide de melanges polyvitaminiques
US5075116A (en) * 1989-04-20 1991-12-24 Lahaye Laboratories, Inc. Composition and method for treatment of macular degeneration
US5366440A (en) * 1989-10-06 1994-11-22 The Beth Israel Hospital Association Methods for treating disease states using oxidized lipoproteins in conjunction with chemotherapeutic effector agents
SE468541B (sv) * 1990-07-17 1993-02-08 Maja Zeidler Koncentrerad blandning innehaallande vitaminer foer tillsats till hudvaardsmedel

Also Published As

Publication number Publication date
AU2311995A (en) 1995-10-30
EP0732927B1 (de) 2002-10-30
FR2718353A1 (fr) 1995-10-13
DE69528695T2 (de) 2003-07-31
DE69528695D1 (de) 2002-12-05
WO1995027491A1 (fr) 1995-10-19
FR2718353B3 (fr) 1996-06-28
US6020333A (en) 2000-02-01
EP0732927A1 (de) 1996-09-25

Similar Documents

Publication Publication Date Title
ATE226824T1 (de) Zusammensetzungen mit u.a. riboflavin zur lokaler schützung von genitalen und rectalen schleimhäuten
WO1998056761A3 (en) Benzimidazole derivatives
NZ516347A (en) Indanyl-substituted benzenecarboxamides, process for their preparation, their use as a medicament and pharmaceutical formulations containing them
WO2002069993A8 (de) Cannabis extrakten pharmazeutische zusammensetzung
NO304889B1 (no) Imidazopyridiner og deres anvendelse ved fremstilling av legemidler til behandling av mave-tarm-sykdommer
ZA894728B (en) A new pharmaceutical formulation as well as a process for its preparation
ES2137138A1 (es) Derivados de pirazolinas, su preparacion y su aplicacion como medicamentos.
UA88523C2 (ru) Фармацевтический препарат рофлумиласта для местного применения
IT1276783B1 (it) Formulazioni farmaceutiche e dietetiche per la profilassi e la cura di affezioni gastrointestinali
AU9671798A (en) Allosteric adenosine receptor modulators
BR9406893A (pt) Emprego de nona- e decapeptideos para a preparação de um medicamento para o combate da aids
MX9501848A (es) Nuevos compuestos polienicos, composiciones farmaceuticas y cosmeticas que los contienen y sus usos.
BG105173A (en) Novel salt form of pantoprazole
HK87094A (en) Use of buspirone for preparing pharmaceutical compositions for alleviation of phobic anxiety
US20110064826A1 (en) Composition for treating skin lesions
CA2136404A1 (fr) Composition solide mucoadhesive, therapeutique ou hygienique, pour administration par application sur la muqueuse buccale ou nasale
AU5988086A (en) New carboxylic acid derivatives, processes for the preparation thereof, the use thereof and pharmaceutical compositions containing them
IT1170214B (it) Composizione farmaceutica per la cura delle arteriopatie periferiche
ATE83376T1 (de) Chinolinylaether tetrazole als mittel zur behandlung von hyperempfindlichen krankheiten.
NO962752L (no) Anvendelse av 2,3-diaryl-1-benzopyranderivater ved fremstilling av et medikament for behandling og forebyggelse av benvevstap og osteoporose
AR035946A1 (es) Composiciones farmaceuticas estrogenicas para usar en el tratamiento de desordenes en mujeres perimenopausicas, menopausicas o posmenopausicas, y usos de dichas composiciones para la preparacion de medicamentos
AU3942989A (en) Anti-irritant and desensitizing compositions and methods of their use
EP1389468A4 (de) Zusammensetzungen zur förderung der knochenfrakturheilung
IE820539L (en) Substituted biphenyl compounds
AU7775398A (en) Novel glycosylated ginkgolide derivatives, their application as medicines and pharmaceutical compositions

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties